Axtria Stock

axtria.comHealthcare / Healthcare softwareFounded: 2010Funding to Date: $159.97MM

Axtria is a global provider of cloud software and data analytics to the Life Sciences industry. Founded in 2010 by Jaswinder Chadha and Navdeep (Navi) Chadha, Axtira is headquartered in Berkeley Heights, New Jersey. Helping Life Sciences companies transform the product commercialization journey to drive sales growth and improve healthcare outcomes for patients.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Axtria, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Axtria’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Axtria.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Axtria investors also invested in these private companies

Deshpande Foundation
Helion Venture Partners
Richard Braddock
Amarpreet Sawhney
Fred Khosravi

Team

Management Team

Navdeep (Navi) Chadha
Co-Founder & Chief Technology Officer
Jaswinder Chadha
Co-Founder & Chief Executive Officer

Board Members

Sanjeev Aggarwal
Helion Venture Partners
Richard Braddock
Pypestream

Axtria stock FAQs

plusminus

Can you buy Axtria stock?

As Axtria is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Axtria, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Axtria stock?

To invest in a private company like Axtria through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Axtria stock?

Yes, you may be able to sell your Axtria stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Axtria stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Axtria stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Axtria a public company?

No, Axtria is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Axtria’s stock price?

Axtria is a privately held company and therefore does not have a public stock price. However, you may access Axtria’s private market stock price with Forge Data.
plusminus

What is Axtria’s stock ticker symbol?

Axtria does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Axtria, a global leader in cloud software and data analytics for the life sciences industry, has published its annual customer engagement planning and execution benchmarking study. The study reveals industry trends and best practices, and shows that 83% of large companies have semi or fully automated data platforms, compared to less than half for smaller companies. The report also highlights the increasing prevalence of Next Best Action strategies in customer engagement.
New Jersey-based firm Axtria is seeking to reshape the pharmaceutical sector with technology. The company provides cloud-based tools to help pharmaceutical companies track sales, marketing operations, and fast-track drug development cycles. Axtria has transitioned to a software-as-a-service model and launched five flagship products, with 50% of its revenue coming from these products. The company plans to further innovate and develop a cloud-based product for drug development based largely on data.
IT firm Axtria plans to hire over 1,000 employees in data science, software development, and data engineering across its offices in India over the next eight months. The move follows increased demand for data-driven analytics solutions and AI technology. Axtria has recently expanded to Noida and plans further expansion in Pune and Hyderabad in 2023.
The global market for Internet of Things (IoT) Analytics is projected to reach $166.5 Billion by 2030, growing at a CAGR of 26.9% from 2022-2030, according to a report by ResearchAndMarkets.com. The manufacturing sector is predicted to record a 30% CAGR and reach $55.9 Billion by the end of the analysis period.
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.